PCSK9 and atherosclerosis: To promote the development of atherosclerosis, HFHC diet–fed mice were administered proprotein convertase subtilisin/kexin type 9–adeno-associated virus (PCSK9-AAV) followed by daily administration of semaglutide or saline (control) for 18 weeks.